Literature DB >> 9019377

Screening for diabetic retinopathy. Initiation and frequency.

J K Kristinsson1, J R Gudmundsson, E Stefánsson, F Jónasson, I Gíslason, A V Thórsson.   

Abstract

A screening program for diabetic eye disease was established in Iceland in 1980. Diabetics involved in the screening program have a low prevalence of blindness, 1% in type 1 and 1.6% in type 2. We examined ways to make the screening program more efficient by identifying subgroups at low risk of developing eye disease that require treatment and therefore need less frequent screening. We studied whether diabetic eye disease screening programs may be trimmed by excluding children and examining diabetics without retinopathy biannually. Our results indicate that diabetic children under the age of 12 years do not need regular screening for eye disease. Biannual examinations seem to suffice in type 1 and 2 diabetic patients without retinopathy. However, in a setting where the eye clinic is located apart from the diabetes clinics, biannual examinations present practical problems which could result in a less effective screening for diabetic eye disease.

Entities:  

Mesh:

Year:  1995        PMID: 9019377     DOI: 10.1111/j.1600-0420.1995.tb00329.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  8 in total

1.  Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy.

Authors:  T Aspelund; O Thornórisdóttir; E Olafsdottir; A Gudmundsdottir; A B Einarsdóttir; J Mehlsen; S Einarsson; O Pálsson; G Einarsson; T Bek; E Stefánsson
Journal:  Diabetologia       Date:  2011-07-27       Impact factor: 10.122

2.  Biennial eye screening in patients with diabetes without retinopathy: 10-year experience.

Authors:  E Olafsdóttir; E Stefánsson
Journal:  Br J Ophthalmol       Date:  2007-07-12       Impact factor: 4.638

3.  Individualised risk assessment for diabetic retinopathy and optimisation of screening intervals: a scientific approach to reducing healthcare costs.

Authors:  S H Lund; T Aspelund; P Kirby; G Russell; S Einarsson; O Palsson; E Stefánsson
Journal:  Br J Ophthalmol       Date:  2015-09-16       Impact factor: 4.638

Review 4.  Extending the diabetic retinopathy screening interval beyond 1 year: systematic review.

Authors:  Sian Taylor-Phillips; Hema Mistry; Rachael Leslie; Dan Todkill; Alexander Tsertsvadze; Martin Connock; Aileen Clarke
Journal:  Br J Ophthalmol       Date:  2015-01-13       Impact factor: 4.638

5.  Pediatric diabetic retinopathy: experience of a tertiary hospital in Ethiopia.

Authors:  Mulugeta Sitot Shibeshi; Bereket Fantahun; Tedla Kebede; Birkneh Tilahun
Journal:  BMC Res Notes       Date:  2016-02-22

6.  Risk factors associated with retinopathy in young people with type 1 diabetes in Bangladesh.

Authors:  Bedowra Zabeen; Mohammad Zafar Khaled; Lutful Husain; Asma Aktar; Kamrul Huda; Yeasmin Afroz Kamal; Nujhat Choudhury; Kishwar Azad
Journal:  Endocrinol Diabetes Metab       Date:  2020-12-17

Review 7.  Interventions to increase attendance for diabetic retinopathy screening.

Authors:  John G Lawrenson; Ella Graham-Rowe; Fabiana Lorencatto; Jennifer Burr; Catey Bunce; Jillian J Francis; Patricia Aluko; Stephen Rice; Luke Vale; Tunde Peto; Justin Presseau; Noah Ivers; Jeremy M Grimshaw
Journal:  Cochrane Database Syst Rev       Date:  2018-01-15

8.  Pediatric Diabetic Retinopathy: Experience of a Tertiary Hospital in Oman.

Authors:  Puspalata Agroiya; Abdul Hakeem Alrawahi
Journal:  Middle East Afr J Ophthalmol       Date:  2020-01-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.